Of the three new items in this month's OIG Work Plan items, one may have implications for some labs. Access to Medication-Assisted Treatment at Health Centers Issue: Medication-assisted … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: April 2019
May 6, 2019
Among the 10 new Work Plan items this month, three may have potential ramifications for at least some labs. Medicaid Managed Care Organization Denials Issue: The State Medicaid agency and the … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: March 2019
April 15, 2019
This month, there were 16 new Work Plan items. Three of these may have implications for some labs as detailed below. Medicare Market Shares of Mail Order Diabetes Test Strips Issue: The … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: February 2019
February 22, 2019
This month, there were two new Work Plan items. One of these may have implications for some labs and is detailed below. Characteristics of Part D Beneficiaries at Serious Risk of Opioid Misuse or … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: January 2019
January 23, 2019
This month, there were six new Work Plan items. The two pertaining to labs are detailed below. The first one has widespread implications for labs; the second may have implications for some labs 1. … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: November 2018
December 3, 2018
This month, there were six new Work Plan items, two of which have implications for at least some labs. 1. CDC's Oversight of the President's Emergency Plan for AIDS Relief Funds Issue: Through the … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: October 2018
October 19, 2018
October saw five new OIG Work Plan items. One has direct implications for labs, while two have potential implications for some labs. These three items are detailed below. 1. CMS Medicare Beneficiary … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: September 2018
September 27, 2018
Neither of the two new OIG Work Plan items directly impacts labs but both address areas of national concern and have potential long-term implications on at least some labs. 1. Follow-Up Review of … [Read more...]
COMPLIANCE PLANS
TOOL: Model Specimen Processing Fees Compliance Policy
September 27, 2018
Here's a Model Policy your lab can adapt to ensure that specimen processing fee arrangements with referral sources don't violate the Anti-Kickback and Stark laws. … [Read more...]
COMPLIANCE PLANS
OIG Monthly Work Plan Review: August 2018
September 10, 2018
Of the 12 new Work Plan items, four have direct implications for labs and billing of lab tests. 1. Medicare Payments for Clinical Diagnostic Laboratory Tests in 2017: Year 4 of Baseline Data Issue: … [Read more...]
